MScan is a novel promising MUNE method with good reproducibility and clinical potential. MScan and MPS are better at discriminating between ALS patients and healthy controls than MUNIX. Only MScan manages to distinguish patients with less certainty of ALS from healthy controls.
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a b s t r a c t
Objective: To examine inter-and intra-rater reproducibility and sensitivity to motor unit loss of a novel motor unit number estimation (MUNE) method, MScanFit MUNE (MScan), compared to two traditional MUNE methods; Multiple point stimulation MUNE (MPS) and Motor Unit Number Index (MUNIX). Methods: Twenty-two ALS patients and 20 sex-and age-matched healthy controls were included. MPS, MUNIX, and MScan were performed twice each by two blinded physicians. Reproducibility of MUNE values was assessed by coefficient of variation (CV) and intra class correlation coefficient (ICC). Ability to detect motor unit loss was assessed by ROC curves and area under the curve (AUC). The times taken for each of the methods were recorded. Results: MScan was more reproducible than MPS and MUNIX both between and within operators. The mean CV for MScan (12.3%) was significantly lower than for MPS (24.7%) or MUNIX (21.5%). All methods had ICC > 0.94. MScan and Munix were significantly quicker to perform than MPS (6.3 m vs. 13.2 m). MScan (AUC = 0.930) and MPS (AUC = 0.899) were significantly better at discriminating between patients and healthy controls than MUNIX (AUC = 0.831). Conclusions: MScan was more consistent than MPS or MUNIX and better at distinguishing ALS patients from healthy subjects. Significance: MScan may improve detection and assessment of motor unit loss. Ó 2017 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.
Introduction
Amyotrophic lateral sclerosis (ALS) is a fatal neuromuscular disease characterized by a decline in upper and lower motor neurons and a corresponding denervation of muscle fibers. This leads to progressive paralysis with a fatal outcome within an average of 3 years after diagnosis of the disease (Couratier et al., 2016) .
Overall, there is no method that can measure the exact number of motor units. Nerve conduction studies and electromyography cannot provide accurate information about the number of motor unit loss. Because of collateral sprouting, where healthy axons take over the muscle territory of axons that have been lost, compound 
